About COVID-RED

COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
READ MORE >>

NEWS

LEES MEER
Artikel COVID-RED in VAPvisie-Analyse
Aug
25
2021
Lees meer >
LEES MEER
Publicatie COVID-RED onderzoeksprotocol
Aug
12
2021
Lees meer >

Twitter

Wat zouden jullie graag terug willen lezen in onze nieuwe nieuwsbrief of op social media?

#covid19 #trials #corona

De herinneringen voor de vingerprikken zijn weer verstuurd. Als je nog niet in de gelegenheid bent geweest om dit te versturen, dan is dat geen probleem. Wij ontvangen de vingerprik graag zo snel als voor jou mogelijk. Heb jij de vingerprik al uitgevoerd en op de post gedaan?

Instagram

COVID-RED

Uw hulp in de strijd tegen corona

The COVID-RED consortium

The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

OUR CONSORTIUM
»

The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.